Two Sigma Advisers’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,100
| Closed | -$817K | – | 2424 |
|
|
2025
Q2 | $817K | Buy |
+2,100
| New | +$845K | ﹤0.01% | 1533 |
|
|
2025
Q1 | – | Sell |
-257,000
| Closed | -$94.8M | – | 2439 |
|
|
2024
Q4 | $94.8M | Buy |
257,000
+240,400
| +1,448% | +$101M | 0.22% | 83 |
|
|
2024
Q3 | $8.63M | Buy |
+16,600
| New | +$8.87M | 0.02% | 525 |
|
|
2024
Q2 | – | Sell |
-63,700
| Closed | -$33M | – | 2508 |
|
|
2024
Q1 | $33M | Sell |
63,700
-237,800
| -79% | -$118M | 0.08% | 244 |
|
|
2023
Q4 | $142M | Sell |
301,500
-498,000
| -62% | -$230M | 0.33% | 70 |
|
|
2023
Q3 | $348M | Buy |
799,500
+279,900
| +54% | +$127M | 0.89% | 19 |
|
|
2023
Q2 | $231M | Buy |
519,600
+267,300
| +106% | +$123M | 0.59% | 35 |
|
|
2023
Q1 | $116M | Buy |
252,300
+237,200
| +1,571% | +$113M | 0.3% | 81 |
|
|
2022
Q4 | $7.75M | Sell |
15,100
-2,000
| -12% | -$1.02M | 0.02% | 592 |
|
|
2022
Q3 | $7.77M | Sell |
17,100
-25,095
| -59% | -$12M | 0.02% | 569 |
|
|
2022
Q2 | $20.4M | Sell |
42,195
-84,467
| -67% | -$41.8M | 0.06% | 326 |
|
|
2022
Q1 | $62.2M | Sell |
126,662
-242,000
| -66% | -$111M | 0.17% | 135 |
|
|
2021
Q4 | $171M | Sell |
368,662
-239,900
| -39% | -$101M | 0.43% | 64 |
|
|
2021
Q3 | $227M | Sell |
608,562
-41,200
| -6% | -$15.7M | 0.59% | 40 |
|
|
2021
Q2 | $248M | Sell |
649,762
-157,000
| -19% | -$60M | 0.65% | 29 |
|
|
2021
Q1 | $290M | Sell |
806,762
-62,100
| -7% | -$20M | 0.8% | 15 |
|
|
2020
Q4 | $279M | Sell |
868,862
-85,700
| -9% | -$26.3M | 0.75% | 21 |
|
|
2020
Q3 | $256M | Buy |
954,562
+130,000
| +16% | +$35M | 0.73% | 26 |
|
|
2020
Q2 | $217M | Buy |
824,562
+417,300
| +102% | +$111M | 0.64% | 29 |
|
|
2020
Q1 | $92.5M | Sell |
407,262
-318,400
| -44% | -$86.8M | 0.35% | 62 |
|
|
2019
Q4 | $219M | Buy |
725,662
+307,800
| +74% | +$84.7M | 0.51% | 40 |
|
|
2019
Q3 | $100M | Buy |
+417,862
| New | +$114M | 0.25% | 104 |
|
|
2019
Q2 | – | Sell |
-66,697
| Closed | -$19.1M | – | 2352 |
|
|
2019
Q1 | $19.1M | Sell |
66,697
-23,338
| -26% | -$6.75M | 0.05% | 430 |
|
|
2018
Q4 | $23.6M | Sell |
90,035
-840,280
| -90% | -$231M | 0.06% | 340 |
|
|
2018
Q3 | $255M | Buy |
930,315
+489,600
| +111% | +$127M | 0.62% | 22 |
|
|
2018
Q2 | $105M | Sell |
440,715
-99,400
| -18% | -$23M | 0.28% | 85 |
|
|
2018
Q1 | $119M | Buy |
540,115
+97,562
| +22% | +$22.9M | 0.32% | 72 |
|
|
2017
Q4 | $99.6M | Sell |
442,553
-12,680
| -3% | -$2.7M | 0.27% | 102 |
|
|
2017
Q3 | $86.4M | Buy |
+455,233
| New | +$86.6M | 0.25% | 110 |
|
|
2017
Q1 | – | Sell |
-1,057,471
| Closed | -$152M | – | 2372 |
|
|
2016
Q4 | $152M | Sell |
1,057,471
-53,179
| -5% | -$7.12M | 0.58% | 25 |
|
|
2016
Q3 | $139M | Sell |
1,110,650
-136,701
| -11% | -$17.7M | 0.59% | 30 |
|
|
2016
Q2 | $164M | Buy |
1,247,351
+1,067,300
| +593% | +$146M | 0.83% | 14 |
|
|
2016
Q1 | $25M | Buy |
180,051
+153,796
| +586% | +$20.6M | 0.14% | 181 |
|
|
2015
Q4 | $3.66M | Sell |
26,255
-23,816
| -48% | -$3.28M | 0.02% | 543 |
|
|
2015
Q3 | $7.01M | Buy |
50,071
+36,251
| +262% | +$5.45M | 0.04% | 390 |
|
|
2015
Q2 | $2.27M | Buy |
+13,820
| New | +$2.21M | 0.02% | 750 |
|
|
2015
Q1 | – | Sell |
-3,013
| Closed | -$379K | – | 2035 |
|
|
2014
Q4 | $379K | Buy |
3,013
+1,198
| +66% | +$148K | ﹤0.01% | 1801 |
|
|
2014
Q3 | $217K | Sell |
1,815
-10,600
| -85% | -$1.22M | ﹤0.01% | 2091 |
|
|
2014
Q2 | $1.34M | Buy |
12,415
+9,102
| +275% | +$938K | 0.01% | 1015 |
|
|
2014
Q1 | $330K | Sell |
3,313
-52,565
| -94% | -$4.75M | ﹤0.01% | 1809 |
|
|
2013
Q4 | $5.16M | Buy |
+55,878
| New | +$4.97M | 0.05% | 383 |
|
Other funds holding ELV
Two Sigma Advisers's ELV Position: Q3 2025 in Review
Two Sigma Advisers sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 2,100 shares — an estimated $817K sold.
Two Sigma Advisers first reported a position in ELV in Q4 2013 and held it in 41 quarters. The position peaked at $348M in Q3 2023. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.
- Two Sigma Advisers reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
- Two Sigma Advisers sold 2,100 Elevance Health shares in Q3 2025, an estimated $817K.
- Two Sigma Advisers first reported a position in Elevance Health in Q4 2013 and held it in 41 quarters.
- Two Sigma Advisers's Elevance Health position peaked at $348M in Q3 2023.
- 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.
Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.